Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00HIB
|
||||
| Former ID |
DNC000378
|
||||
| Drug Name |
Caffeic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H8O4
|
||||
| InChI |
InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2+
|
||||
| InChIKey |
QAIPRVGONGVQAS-DUXPYHPUSA-N
|
||||
| CAS Number |
CAS 331-39-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
4422, 4652, 106262, 491233, 598027, 611234, 855772, 3132907, 8001577, 8034051, 8145667, 9287032, 10518882, 11537800, 14718166, 15171314, 17404771, 22394958, 22395875, 24278290, 24881776, 24881777, 26612575, 26679411, 26746990, 26751505, 26758358, 29203902, 33749646, 46504491, 48413363, 48422454, 49699041, 49703794, 49747047, 49855355, 50104061, 50104062, 50104063, 50104064, 50104065, 53777314, 53787916, 56422203, 57408588, 57651712, 58034488, 74966461, 81040420, 81091163
|
||||
| ChEBI ID |
ChEBI:17395
|
||||
| Target and Pathway | |||||
| Target(s) | Arachidonate 5-lipoxygenase | Target Info | Inhibitor | [2], [3], [4] | |
| BioCyc Pathway | Aspirin-triggered lipoxin biosynthesis | ||||
| Resolvin D biosynthesis | |||||
| Leukotriene biosynthesis | |||||
| Lipoxin biosynthesis | |||||
| Aspirin triggered resolvin D biosynthesis | |||||
| Aspirin triggered resolvin E biosynthesis | |||||
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Toxoplasmosis | |||||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| WikiPathways | Vitamin D Receptor Pathway | ||||
| Arachidonic acid metabolism | |||||
| Eicosanoid Synthesis | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5155). | ||||
| REF 2 | Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126. J Neurosci Res. 2001 Sep 15;65(6):565-72. | ||||
| REF 3 | Protection of mouse brain from aluminum-induced damage by caffeic acid. CNS Neurosci Ther. 2008 Spring;14(1):10-6. | ||||
| REF 4 | Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity. Neurosci Lett. 2008 Nov 7;445(1):1-6. Epub 2008 Aug 22. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.